Cited by 149Radiomics and Machine Learning in Medical ImagingBreast Cancer Treatment StudiesMRI in cancer diagnosis

Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data

Open access
Guo, Wentian, Li, Hui, Zhu, Yitan, Lan, Li, Yang, Shengjie, Drukker, Karen, Morris, Elizabeth A., Burnside, Elizabeth S. +4 more·2015·Journal of Medical Imaging

Abstract

Genomic and radiomic imaging profiles of invasive breast carcinomas from The Cancer Genome Atlas and The Cancer Imaging Archive were integrated and a comprehensive analysis was conducted to predict clinical outcomes using the radiogenomic features. Variable selection via LASSO and logistic regression were used to select the most-predictive radiogenomic features for the clinical phenotypes, including pathological stage, lymph node metastasis, and status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Cross-validation with receiver operating characteristic (ROC) analysis was performed and the area under the ROC curve (AUC) was employed as the prediction metric. Higher AUCs were obtained in the prediction of pathological stage, ER, and PR status than for lymph node metastasis and HER2 status. Overall, the prediction performances by genomics alone, radiomics alone, and combined radiogenomics features showed statistically significant correlations with clinical outcomes; however, improvement on the prediction performance by combining genomics and radiomics data was not found to be statistically significant, most likely due to the small sample size of 91 cancer cases with 38 radiomic features and 144 genomic features.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1117/1.jmi.2.4.041007

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The breast phenotype group in TCIA defined a total of 38 radiomics features driving reproducible radiogenomics research hypothesis testing.

    “In this sequence, the breast phenotype group defined a total of 38 radiomics features driving reproducible radiogenomics research hypothesis testing [234].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Hui Li has been working on quantitative imaging analysis at the University of Chicago since 2001. His research interests include breast cancer risk assessment and computer-aided diagnosis on Journal of Medical Imaging 041007-11 Oct-Dec 2015 • Vol. 2(

Cited by

Sorted by citations

Authors
Guo, W., Li, H., Zhu, Y., Lan, L., Yang, S., Drukker, K., Morris, E. A., Burnside, E. S., Whitman, G. J., Giger, M. L., Ji, Y., & Research Group, T. B. P.
Affiliations
  • Fudan University (CN)
  • University of Chicago (US)
  • Endeavor Health (US)
  • The Univ. of Chicago
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Wisconsin–Madison (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • http://www.cancerimagingarchive.net/
Venue
Journal of Medical Imaging
Published
2015-09-23
Volume
2
Issue
04
Pages
1-12
ISSN
  • 2329-4302 (ISSN-L)
  • 2329-4310
OpenAlex
W1687542094
Cited by
148
References
38
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 14 · 2022: 15 · 2021: 18 · 2020: 22 · 2019: 17 · 2018: 31 · 2017: 17 · 2016: 4
FWCI
14.03
Type
journal article
Language
en
Open access
Locations
  • Journal of medical imaging (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fudan University
  • National Institutes of Health
  • National Cancer Institute (U01CA195564, K24CA194251, R01CA132897, R01CA127379, P30CA014520)
  • National Institute of Allergy and Infectious Diseases (U54AI117924)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Keywords
invasive breast cancer, radiogenomics, radiomics, genomic data integration, clinical phenotype prediction, pathological stage, lymph node metastasis, hormone receptor status, HER2 status, breast cancer prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review